Strategically planning your launch sequencing can have a pivotal impact on your launch success. When preparing for launch in multiple therapeutic indications, it’s essential to carefully plan which indication to launch in first, and which to reserve as a secondary indication. If you’re planning to launch, you’ll need to consider the most appropriate launch order by carefully balancing the clinical priorities such as higher unmet need together with the commercial opportunity, focusing in on key markets where you could achieve the greatest market share.
Confidently recognizing and addressing these key considerations is where VISFO comes in. Our highly knowledgeable team has extensive experience when it comes to launch prioritization across multiple markets and therapy areas for clients.
By blending our strengths in data science with years of hands-on industry experience, we can confidently explore your chosen indication, looking at the clinical and commercial opportunity and providing you with actionable strategic intelligence to support your launch strategy. Our account management approach is a collaborative one - we work with you to understand your project timings and key milestones. All our analyses are delivered through our one-stop portal where you can access the data and liaise directly with your account lead to shape the outputs to suit your individual needs.
What we offer:
- Epidemiology
- ~The potential size of the addressable patient population
- Clinical landscaping
- ~The unmet need and burden of disease
- Competitor analysis
- ~The current and future competitive landscape and potential opportunities within target launch indication(s) and markets of interest
- Price landscaping
- ~Potential price benchmarks within the target indication(s) and markets